Docking-based generative approaches in the search for new drug
candidates
- URL: http://arxiv.org/abs/2312.13944v1
- Date: Wed, 22 Nov 2023 11:37:09 GMT
- Title: Docking-based generative approaches in the search for new drug
candidates
- Authors: Tomasz Danel, Jan {\L}\k{e}ski, Sabina Podlewska, Igor T. Podolak
- Abstract summary: We propose a new taxonomy for docking-based generative models.
We discuss the most promising directions for further development of generative protocols coupled with docking.
- Score: 2.407154340925365
- License: http://creativecommons.org/licenses/by-nc-nd/4.0/
- Abstract: Despite the great popularity of virtual screening of existing compound
libraries, the search for new potential drug candidates also takes advantage of
generative protocols, where new compound suggestions are enumerated using
various algorithms. To increase the activity potency of generative approaches,
they have recently been coupled with molecular docking, a leading methodology
of structure-based drug design. In this review, we summarize progress since
docking-based generative models emerged. We propose a new taxonomy for these
methods and discuss their importance for the field of computer-aided drug
design. In addition, we discuss the most promising directions for further
development of generative protocols coupled with docking.
Related papers
- Hierarchical Reinforcement Learning for Temporal Abstraction of Listwise Recommendation [51.06031200728449]
We propose a novel framework called mccHRL to provide different levels of temporal abstraction on listwise recommendation.
Within the hierarchical framework, the high-level agent studies the evolution of user perception, while the low-level agent produces the item selection policy.
Results observe significant performance improvement by our method, compared with several well-known baselines.
arXiv Detail & Related papers (2024-09-11T17:01:06Z) - New methods for drug synergy prediction: a mini-review [2.1024950052120417]
More than thirty original machine learning methods have been published since 2021.
We aim to put these papers under a unifying lens by highlighting the core technologies, the data sources, the input data types and synergy scores used in the methods.
Our finding is that the best methods accurately solve the synergy prediction scenarios involving known drugs or cell lines while the scenarios involving new drugs or cell lines still fall short of an accurate prediction level.
arXiv Detail & Related papers (2024-04-03T05:44:03Z) - A Survey of Generative AI for de novo Drug Design: New Frontiers in Molecule and Protein Generation [8.9311469963107]
Generative models for de novo drug design focus on the creation of novel biological compounds entirely from scratch.
Rapid development in the field, combined with the inherent complexity of the drug design process, creates a difficult landscape for new researchers to enter.
In this survey, we organize de novo drug design into two overarching themes: small molecule and protein generation.
arXiv Detail & Related papers (2024-02-13T16:56:31Z) - Deep Learning Methods for Small Molecule Drug Discovery: A Survey [6.61864409597243]
We review various applications of deep learning in drug discovery.
These include molecule generation, molecular property prediction, retrosynthesis prediction, and reaction prediction.
We conclude by identifying remaining challenges and discussing the future trend for deep learning methods in drug discovery.
arXiv Detail & Related papers (2023-03-01T08:16:38Z) - Drug Synergistic Combinations Predictions via Large-Scale Pre-Training
and Graph Structure Learning [82.93806087715507]
Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation.
Deep learning models have emerged as an efficient way to discover synergistic combinations.
Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
arXiv Detail & Related papers (2023-01-14T15:07:43Z) - Tailoring Molecules for Protein Pockets: a Transformer-based Generative
Solution for Structured-based Drug Design [133.1268990638971]
De novo drug design based on the structure of a target protein can provide novel drug candidates.
We present a generative solution named TamGent that can directly generate candidate drugs from scratch for a given target.
arXiv Detail & Related papers (2022-08-30T09:32:39Z) - Retrieval-based Controllable Molecule Generation [63.44583084888342]
We propose a new retrieval-based framework for controllable molecule generation.
We use a small set of molecules to steer the pre-trained generative model towards synthesizing molecules that satisfy the given design criteria.
Our approach is agnostic to the choice of generative models and requires no task-specific fine-tuning.
arXiv Detail & Related papers (2022-08-23T17:01:16Z) - CorpusBrain: Pre-train a Generative Retrieval Model for
Knowledge-Intensive Language Tasks [62.22920673080208]
Single-step generative model can dramatically simplify the search process and be optimized in end-to-end manner.
We name the pre-trained generative retrieval model as CorpusBrain as all information about the corpus is encoded in its parameters without the need of constructing additional index.
arXiv Detail & Related papers (2022-08-16T10:22:49Z) - Learning To Navigate The Synthetically Accessible Chemical Space Using
Reinforcement Learning [75.95376096628135]
We propose a novel forward synthesis framework powered by reinforcement learning (RL) for de novo drug design.
In this setup, the agent learns to navigate through the immense synthetically accessible chemical space.
We describe how the end-to-end training in this study represents an important paradigm in radically expanding the synthesizable chemical space.
arXiv Detail & Related papers (2020-04-26T21:40:03Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.